Company news

Branded Legacy Inc. (OTC:BLEG) news

Branded Legacy Inc. news releases on 6ix. Latest, Sep 29, 2026: Branded Legacy Announces Acquisition of Kharkiv, Ukraine Facility to Support Autonomous…

Branded Legacy Inc. (OTC:BLEG) news

Press releases & updates

Branded Legacy Announces Acquisition of Kharkiv, Ukraine Facility to Support Autonomous Defense Development and Name Change to T4 Robotics

Branded Legacy, Inc. (OTC: BLEG) Finalizes Acquisition of Autonomous Defense Company

Branded Legacy, Inc. Announces Leadership Transition: Appoints New CEO and Sole Director

Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares

Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal

Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership

Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary

Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development

Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray

Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market

Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development

Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver

Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions

Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways

Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery

Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

Branded Legacy, Inc. Secures Key Client with $70,000,000 Annual Revenue; Expects to Surpass $10,000,000 in 2025

Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement

Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product

Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count

Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million

Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract

Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation

Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc.

Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC

Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL

Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market

Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00

Branded Legacy, Inc. Reduces Debt by 1.5 Million

Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M

Branded Legacy, INC Successfully Closes Acquisition of All In Extracts, LLC

Branded Legacy, Inc. ($BLEG) Retires Additional 442 Million Common Shares, Surpassing Initial Commitment

Branded Legacy, Inc. (BLEG) to Feature in an Exclusive Podcast Interview with Buffalo Fireside Chats

Branded Legacy, Inc. (BLEG) Announces Retirement of 400,000,000 Common Shares, Achieving Target of 2 Billion in Share Reductions with More to Come

Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets

Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares

Branded Legacy Signs Letter of Intent to Acquire $6 million in Assets and Additional Facility Space

Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements

Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow

Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC

Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion

Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans

Branded Legacy, Inc. Successfully Completes Acquisition of Rocket Web Development and Design

Branded Legacy Inks Letter of Intent to acquire Digital Marketing Firm

Branded Legacy, Inc. Welcomes New Management Team and Announces Strategic Transformation Into Biotech Industry

Branded Legacy, Inc. Retains Counsel to File S-1 Registration Statement

Branded Legacy, Inc. Unveils Strategic Transformation in Investor Teleconference

Branded Legacy, Inc. Signs Letter of Intent to Acquire a Mycology Research Lab